MedTrace Logo

Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery

NCT01842568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15989

Last updated 2025-07-31

No results posted yet for this study

Summary

Worldwide over 2 million adults (\>30,000 Canadians) undergo heart surgery annually. Although heart surgery provides important survival benefits, it is associated with potential major complications such as death, stroke, and heart attack. There is promising evidence that measurement of heart injury markers after surgery will identify patients at risk of death or major complications.

This study will determine the current incidence of major complications in a representative sample of 15,000 contemporary adult patients undergoing heart surgery. Knowing the current burden of complications will inform clinicians, administrators, government and granting agencies about resources required to address the problem. This study will also establish the role of measuring heart injury markers to identify important heart injury after heart surgery and the proportion that would go undetected without routine heart injury marker monitoring. This information will facilitate further studies of timely interventions. In summary, the VISION Cardiac Surgery Study addresses fundamental questions that will have profound public health implications given the millions of adults worldwide who undergo heart surgery annually.

Conditions

Sponsors & Collaborators

  • Abbott Diagnostics Division

    collaborator INDUSTRY

  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • P.J. Devereaux, MD, PhD · McMaster University

  • Andre Lamy, MD · McMaster University

  • Richard Whitlock, MD · McMaster University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2022-05-31
Completion
2025-07-31

Countries

  • United States
  • Australia
  • Brazil
  • Canada
  • China
  • Hong Kong
  • Italy
  • Malaysia
  • Poland
  • Russia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01842568 on ClinicalTrials.gov